In vivo metabolic imaging identifies lipid vulnerability in a preclinical model of Her2+/Neu breast cancer residual disease and recurrence.

NPJ Breast Cancer · 2022 · PMC9512922 · PMID 36163365

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

Though there is no significant change in average TMRE 60 when comparing Etomoxir-treated tumors with control tumors at each time point, TMRE 60 does show a decreasing trend in the treated group 8-days post dox withdrawal.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.